Login
$URGN
$27.54 -$0.56 (1.99%) After hours

Ownership

13F as of Q2 2026 · 50.6M shares outstanding

Who owns URGN?

By type of holder
Institutions 83.9% Insiders 0.0% Everyone else 16.1%
Concentration Top 10 holders own 46.3%
RTW Investments, LP 9.0% · BlackRock, Inc. 6.3%
Institutional ownership
83.9%
-8.0 pts vs last qtr
Institutional holders
188
+15 vs last qtr
Net shares bought
−4.0M
by institutions in Q2 2026
New / sold out
40 / 25
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Point72 Asset Management, L.P. NEW +1.5M
  • SG Americas Securities, LLC +395.1K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Toronto Dominion Bank SOLD OUT −2.6M
  • Paradigm Biocapital Advisors LP SOLD OUT −1.7M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$4.54M
9 notices from 4 people
Shares covered
113.8K
0.23% of the company
Arranged in advance
23%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$1.4M$2.9MDecJanFeb 2026: $261.5K without a planFebMarAprMay 2026: $300.0K under a 10b5-1 planMayJun 2026: $350.1K under a 10b5-1 planJun 2026: $140.2K without a planJunJul 2026: $400.0K under a 10b5-1 planJulAug 2026: $2.9M without a planAugSep 2026: $105.4K without a planSepOct 2026: $89.6K without a planOctNov
Largest proposed sellers
  • Schoenberg Mark Officer $4.34M
  • Christopher Degnan Officer $89.6K

Sign up to see all 4.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2017–FY2025
+395.2%
+22.14% a year
Each share's claim on the business
−79.8%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $163M
over 9 fiscal years
Diluted shares, split-adjusted
9.4M29.0M48.6M2017: 9.7M shares'172018: 15.8M shares'182019: 20.5M shares'192020: 21.8M shares'202021: 22.3M shares'212022: 22.8M shares'222023: 28.8M shares'232024: 42.9M shares'242025: 48.1M shares'25
Buybacks Stock-based comp
$0$15.3M$30.6M2017 buybacks: $02017 stock comp: $6.3M'172018 buybacks: $02018 stock comp: $30.6M'182019 buybacks: $02019 stock comp: $30.0M'192020 buybacks: $02020 stock comp: $28.0M'202021 buybacks: $02021 stock comp: $23.1M'212022 buybacks: $02022 stock comp: $10.6M'222023 buybacks: $02023 stock comp: $9.3M'232024 buybacks: $02024 stock comp: $13.1M'242025 buybacks: $02025 stock comp: $12.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years28% 3–5 years14% 1–3 years31% Under 1 year27%
Quarterly turnover
14.6%
of institutional shares changed hands
Top 10 managers, median time held
1.8 years

Super Investors

Investment managers reporting URGN on Form 13F
RI
RTW Investments, LP
Shares
4.5M
% of company
8.99%
Change vs last qtr
Unchanged
Held since
2021
B
BlackRock, Inc.
Shares
3.2M
% of company
6.33%
Change vs last qtr
+355.9K (+12.5%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding UroGen Pharma Ltd., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting URGN on Form N-PORT; together they hold 3.5% of the company
SC
American Century Mutual Funds, Inc.
Position value
$33.5M
% of company
1.73%
% of the fund
0.60%
As of
July 31, 2026
VR
Vanguard Scottsdale Funds
Position value
$10.5M
% of company
0.48%
% of the fund
0.06%
As of
August 31, 2026

23 more funds behind a free account

See every fund holding UroGen Pharma Ltd. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
FC
Fred Cohen
5%+ holder13D · 1.9%
Shares
838.6K
% of company
1.66%
Change vs last qtr
—
Held since
—
MC
Monograph Capital Holdings Advisors, LLC
5%+ holder13D · 1.8%
Shares
838.6K
% of company
1.66%
Change vs last qtr
—
Held since
—

2 more holders behind a free account

See every insider and 5%+ holder of UroGen Pharma Ltd..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support